Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127597721 | 12759772 | 1 | I | 20160908 | 20160919 | 20160919 | EXP | GB-NORTHSTAR HEALTHCARE HOLDINGS-GB-2016NSR001845 | NORTHSTAR | TURNEY R, SKITTRALL JP, DONOVAN J, AGRANOFF D. DRUG REACTION, EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) SYNDROME SECONDARY TO ALLOPURINOL WITH EARLY LYMPHADENOPATHY AND SYMPTOM RELAPSE. BMJ CASE REP. 2015;DOI:10.1136/BCR-2015-211222 | 73.00 | YR | F | Y | 84.20000 | KG | 20160919 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127597721 | 12759772 | 1 | PS | ALLOPURINOL. | ALLOPURINOL | 1 | UNK | Y | 78253 | ||||||||||
127597721 | 12759772 | 2 | SS | PHENOXYMETHYLPENICILLIN | PENICILLIN V | 1 | UNK | U | 0 | ||||||||||
127597721 | 12759772 | 3 | C | ASPIRIN. | ASPIRIN | 1 | UNK | U | 0 | ||||||||||
127597721 | 12759772 | 4 | C | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | UNK | U | 0 | ||||||||||
127597721 | 12759772 | 5 | C | DOSULEPIN HYDROCHLORIDE | DOTHIEPIN HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
127597721 | 12759772 | 6 | C | INDAPAMIDE. | INDAPAMIDE | 1 | UNK | U | 0 | ||||||||||
127597721 | 12759772 | 7 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | UNK | U | 0 | ||||||||||
127597721 | 12759772 | 8 | C | LOSARTAN. | LOSARTAN | 1 | UNK | U | 0 | ||||||||||
127597721 | 12759772 | 9 | C | SIMVASTATIN. | SIMVASTATIN | 1 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127597721 | 12759772 | 1 | Product used for unknown indication |
127597721 | 12759772 | 2 | Product used for unknown indication |
127597721 | 12759772 | 3 | Product used for unknown indication |
127597721 | 12759772 | 4 | Product used for unknown indication |
127597721 | 12759772 | 5 | Product used for unknown indication |
127597721 | 12759772 | 6 | Product used for unknown indication |
127597721 | 12759772 | 7 | Product used for unknown indication |
127597721 | 12759772 | 8 | Product used for unknown indication |
127597721 | 12759772 | 9 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127597721 | 12759772 | OT |
127597721 | 12759772 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127597721 | 12759772 | Breast mass | |
127597721 | 12759772 | Chills | |
127597721 | 12759772 | Conjunctivitis | |
127597721 | 12759772 | Diarrhoea | |
127597721 | 12759772 | Drug reaction with eosinophilia and systemic symptoms | |
127597721 | 12759772 | Dyspnoea | |
127597721 | 12759772 | Eosinophilia | |
127597721 | 12759772 | Hepatitis | |
127597721 | 12759772 | Hidradenitis | |
127597721 | 12759772 | International normalised ratio increased | |
127597721 | 12759772 | Lip blister | |
127597721 | 12759772 | Lymphadenopathy | |
127597721 | 12759772 | Neck mass | |
127597721 | 12759772 | Oedema peripheral | |
127597721 | 12759772 | Periorbital oedema | |
127597721 | 12759772 | Pyrexia | |
127597721 | 12759772 | Rash maculo-papular | |
127597721 | 12759772 | Renal failure | |
127597721 | 12759772 | Visual acuity reduced | |
127597721 | 12759772 | Vomiting | |
127597721 | 12759772 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |